AVINZA Drug Patent Profile

✉ Email this page to a colleague

Which patents cover Avinza, and what generic alternatives are available?

Avinza is a drug marketed by King Pharms Llc and is included in one NDA.

The generic ingredient in AVINZA is morphine sulfate. There are twenty-three drug master file entries for this compound. Thirty-one suppliers are listed for this compound. Additional details are available on the morphine sulfate profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Avinza

A generic version of AVINZA was approved as morphine sulfate by HOSPIRA on September 30^th, 1992.

Sign Up

AI Research Assistant

Questions you can ask:

What is the 5 year forecast for AVINZA?
What are the global sales for AVINZA?
What is Average Wholesale Price for AVINZA?

Summary for AVINZA

US Patents:	0
Applicants:	1
NDAs:	1
Raw Ingredient (Bulk) Api Vendors:	24
Clinical Trials:	7
Patent Applications:	5,414
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for AVINZA
What excipients (inactive ingredients) are in AVINZA?	AVINZA excipients list
DailyMed Link:	AVINZA at DailyMed

Drug patent expirations by year for AVINZA

Recent Clinical Trials for AVINZA

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
National Cancer Institute (NCI)	Early Phase 1
M.D. Anderson Cancer Center	Early Phase 1
Isfahan University of Medical Sciences	Phase 2/Phase 3

See all AVINZA clinical trials

Paragraph IV (Patent) Challenges for AVINZA

Tradename	Dosage	Ingredient	Strength	NDA	ANDAs Submitted	Submissiondate
AVINZA	Extended-release Capsules	morphine sulfate	45 mg and 75 mg	021260	1	2009-08-11
AVINZA	Extended-release Capsules	morphine sulfate	30 mg, 60 mg, 90 mg and 120 mg	021260	1	2007-06-04

US Patents and Regulatory Information for AVINZA

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
King Pharms Llc	AVINZA	morphine sulfate	CAPSULE, EXTENDED RELEASE;ORAL	021260-001	Mar 20, 2002		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
King Pharms Llc	AVINZA	morphine sulfate	CAPSULE, EXTENDED RELEASE;ORAL	021260-006	Dec 18, 2008		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
King Pharms Llc	AVINZA	morphine sulfate	CAPSULE, EXTENDED RELEASE;ORAL	021260-005	Dec 18, 2008		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for AVINZA

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
King Pharms Llc	AVINZA	morphine sulfate	CAPSULE, EXTENDED RELEASE;ORAL	021260-001	Mar 20, 2002	⤷ Sign Up	⤷ Sign Up
King Pharms Llc	AVINZA	morphine sulfate	CAPSULE, EXTENDED RELEASE;ORAL	021260-006	Dec 18, 2008	⤷ Sign Up	⤷ Sign Up
King Pharms Llc	AVINZA	morphine sulfate	CAPSULE, EXTENDED RELEASE;ORAL	021260-003	Mar 20, 2002	⤷ Sign Up	⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

International Patents for AVINZA

See the table below for patents covering AVINZA around the world.

Subscribe to access the full database, or Sign Up
Country	Patent Number	Title	Estimated Expiration
European Patent Office	1023051	FORMULATION MULTIPARTICULAIRE DE MORPHINE ORALE (ORAL MORPHINE MULTIPARTICULATE FORMULATION)	⤷ Sign Up
Denmark	1023051		⤷ Sign Up
Australia	5408098		⤷ Sign Up
>Country	>Patent Number	>Title	>Estimated Expiration

AI Research Assistant

Questions you can ask:

Summary for AVINZA

Recent Clinical Trials for AVINZA

Paragraph IV (Patent) Challenges for AVINZA

Make Better Decisions: Try a trial or see plans & pricing